Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Ultralow-dose binary oncolytic/helper-dependent adenovirus promotes antitumor activity in preclinical and clinical studies

Science Advances(2023)10.1126/sciadv.ade6790Source: DataRank Database

Ultralow-dose binary oncolytic/helper-dependent adenovirus promotes antitumor activity in preclinical and clinical studies is a research paper published in Science Advances (2023). On theSindex it has a DataRank of 0. It has been cited 28 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access28 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 6.12)OA: goldTopics (57)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Caroline E. Porter ORCID,Bora Lim ORCID,Amanda Rosewell Shaw ORCID,Catherine Robertson,Mae Woods ORCID

Live enrichment

PubMed:36989357 PMC:PMC10058234 OpenAlex:https://openalex.org/W4361303325

NHLBI NIH HHS

Grant: T32 HL092332

NCI NIH HHS

Grant: P50 CA126752

NCI NIH HHS

Grant: P30 CA125123

National Institutes of Health

Grant: 5P50CA126752-14

SPORE in Lymphoma

National Institutes of Health

Grant: 3P30CA125123-09S3

Baylor College of Medicine Cancer Center

National Institutes of Health

Grant: 2T32HL092332-16

Training In Cell and Gene Therapy

FWCI

6.12

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.science.org/doi/pdf/10.1126/sciadv.ade6790?download=true

publisherhttps://www.science.org/doi/pdf/10.1126/sciadv.ade6790?download=true

publisherhttps://www.science.org/doi/pdf/10.1126/sciadv.ade6790

journalhttps://doi.org/10.1126/sciadv.ade6790

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36989357

Fields of Study

Virus-based gene therapy researchCAR-T cell therapy researchImmunotherapy and Immune Responses0301 basic medicine03 medical and health sciencesMiceAnimalsOncolytic VirotherapyOncolytic VirusesAdenoviridaeNeoplasmsCytokinesCell Line, TumorTumor Microenvironment

MeSH Terms

AdenoviridaeAnimalsNeoplasmsCytokinesCell Line, TumorOncolytic VirotherapyOncolytic VirusesMiceTumor Microenvironment

Keywords

Oncolytic virusOncolytic adenovirusAbscopal effectImmune systemCancer researchMedicineCD8AntibodyImmunologyProinflammatory cytokineSystemic administrationImmune checkpointImmunotherapyBiologyIn vivoInflammationOncolytic VirotherapyTumorMedical Sciences610Cell LineAdenoviridaeMiceOncolytic VirusesGeriatricsNeoplasmsCell Line, TumorInternal MedicineMedical SpecialtiesMedicine and Health SciencesTumor MicroenvironmentAnimalsCytokinesBiomedicine and Life Sciences

Sustainable Development Goals

SDG 0: Good health and well-being